Arkolith/Insider Trading/LIPO/Form 4

Chancellor Michael B

Chief Medical Officer, Director, 10% OwnerLIPELLA PHARMACEUTICALS INC (LIPO) · full profile →Form 4 · filed Dec 27, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2022Other(J)23K$5.75$132K733K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-22-001648) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML